3-溴异恶唑-5-甲酸甲酯，CAS 登记号 272773-11-2，由济南圣和化工有限公司现货供应，可提供纯度 按批次COA提供(不公开发布) 的规格，下游主要用于有机化学品。支持样品与小批量试用，批量价格请联系我们获取，验收以批次 COA 为准。
有机化学品
每批随货提供 COA；可按需提供 MSDS 及技术文件。邮件注明产品名称与 CAS 号，一个工作日内回复报价。
本页已列出 3-溴异恶唑-5-甲酸甲酯 的 CAS 号：272773-11-2，可与随货 COA 核对。
常见纯度为 按批次COA提供(不公开发布)，包装形式为 按订单/批次确认(不公开发布)，特殊规格可在询价时说明。
主要涉及有机化学品。
来信 info@591daili.com 或 WhatsApp 联系，提供产品名称、CAS 号与数量，确认价格与交期后即可安排发货，验收以批次 COA 为准。
methyl 3-bromoisoxazole-5-carboxylate · CAS 272773-11-2 · C5H4BrNO3.
| CAS Registry Number | 272773-11-2 |
|---|---|
| PubChem CID | 46942161 |
| Molecular formula | C5H4BrNO3 |
| IUPAC name | methyl 3-bromo-1,2-oxazole-5-carboxylate |
| Molecular Weight | 205.99 |
|---|---|
| XLogP3 | 1.6 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 2 |
| Exact Mass | 204.93746 |
| Monoisotopic Mass | 204.93746 |
| Topological Polar Surface Area | 52.3 |
| Heavy Atom Count | 10 |
| Formal Charge | 0 |
| Reported hazard statements | H315 (100%), H319 (100%), H335 (100%) |
|---|
H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]
H319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]
272773-11-2; methyl 3-bromo-1,2-oxazole-5-carboxylate; DTXSID60677535; RefChem:354879; DTXCID60628284; methyl 3-bromoisoxazole-5-carboxylate; MFCD12022344; 3-Bromo-5-isoxazolecarboxylic acidmethylester; Methyl 3-bromo-5-isoxazolecarboxylate; 3-Bromo-5-(methoxycarbonyl)isoxazole; methyl-3-bromoisoxazole-5-carboxylate; XKA77311; Methyl3-bromo-5-isoxazolecarboxylate; AKOS015902275; PS-3994; DA-19265
CAS 272773-11-2; molecular formula C5H4BrNO3; molecular weight — g/mol.
272773-11-2, methyl 3-bromo-1,2-oxazole-5-carboxylate, DTXSID60677535, RefChem:354879, DTXCID60628284, methyl 3-bromoisoxazole-5-carboxylate.
Hazard statements reported: H315, H319, H335.
Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.